메뉴 건너뛰기
New England Journal of Medicine
Volumn 356, Issue 4, 2007, Pages 419-420
The authors reply [10]
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT;
EID: 33846460769     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (10)
References (3)
  • 1
    • 24944441877 scopus 로고    scopus 로고
    • Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLTI, an international multicenter trial
    • Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLTI, an international multicenter trial. Ann Surg 2005;242:302-11.
    • (2005) Ann Surg , vol.242 , pp. 302-311
    • Morton, D.L.1    Cochran, A.J.2    Thompson, J.F.3
  • 2
    • 3042667896 scopus 로고    scopus 로고
    • Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node
    • Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004;17:747-55.
    • (2004) Mod Pathol , vol.17 , pp. 747-755
    • Cochran, A.J.1    Wen, D.R.2    Huang, R.R.3    Wang, H.J.4    Elashoff, R.5    Morton, D.L.6
  • 3
    • 0037986306 scopus 로고    scopus 로고
    • End points and United States Food and Drug Administration approval of oncology drugs
    • Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 2003;21:1404-11.
    • (2003) J Clin Oncol , vol.21 , pp. 1404-1411
    • Johnson, J.R.1    Williams, G.2    Pazdur, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.